Cited by 675Uterine Myomas and TreatmentsRenal cell carcinoma treatmentTuberous Sclerosis Complex Research

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Inherited susceptibility to uterine leiomyomas and renal cell cancer

Open access

Launonen, Virpi, Vierimaa, Outi, Kiuru, Maija, Isola, Jorma, Roth, Stina, Pukkala, Eero, Sistonen, Pertti, Herva, Riitta, Aaltonen, Lauri A.·2001·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.051633798PMC PMC30663

Open this paper in CoChat — free account

Abstract

Herein we report the clinical, histopathological, and molecular features of a cancer syndrome with predisposition to uterine leiomyomas and papillary renal cell carcinoma. The studied kindred included 11 family members with uterine leiomyomas and two with uterine leiomyosarcoma. Seven individuals had a history of cutaneous nodules, two of which were confirmed to be cutaneous leiomyomatosis. The four kidney cancer cases occurred in young (33- to 48-year-old) females and displayed a unique natural history. All these kidney cancers displayed a distinct papillary histology and presented as unilateral solitary lesions that had metastasized at the time of diagnosis. Genetic-marker analysis mapped the predisposition gene to chromosome 1q. Losses of the normal chromosome 1q were observed in tumors that had occurred in the kindred, including a uterine leiomyoma. Moreover, the observed histological features were used as a tool to diagnose a second kindred displaying the phenotype. We have shown that predisposition to uterine leiomyomas and papillary renal cell cancer can be inherited dominantly through the hereditary leiomyomatosis and renal cell cancer ( HLRCC ) gene. The HLRCC gene maps to chromosome 1q and is likely to be a tumor suppressor. Clinical, histopathological, and molecular tools are now available for accurate detection and diagnosis of this cancer syndrome.

Integrity signals

Registry

Crossref · 10.1073/pnas.051633798

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J. R., Yao, M., Duh, F.-M. C., Orcutt, M. L., Stackhouse, T. M., Kuzmin, I., Modi, W. S., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,971
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed Central · Cited by 2,883
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
Schmidt, L. S., Duh, F.-M. C., Chen, F., Kishida, T., Glenn, G. M., Choyke, P. L., Scherer, S. W., Zhuang, Z., Lubensky, I. A., Dean, M. C., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,517
Faster sequential genetic linkage computations.
Cottingham, R. W., Idury, R. M., & Schäffer, A. A. (1993) · Europe PMC (PubMed Central) · Cited by 1,364
Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.
Delahunt, B., & Eble, J. N. (1997) · PubMed · Cited by 714
Data Quality and Quality Control of a Population-Based Cancer Registry: Experience in Finland
Teppo, L., Pukkala, ., & Lehtonen, M. (1994) · Acta Oncologica · doi:10.3109/02841869409098430 · Cited by 648
Hereditary Renal-Cell Carcinoma Associated with a Chromosomal Translocation
Cohen, A. J., Li, F. P., Berg, S., Marchetto, D. J., Tsai, S., Jacobs, S. C., & Brown, R. S. (1979) · New England Journal of Medicine · doi:10.1056/nejm197909133011107 · Cited by 643
Tumors of the Kidney, Bladder, and Related Urinary Structures
Murphy, W. M., Grignon, D. J., & Perlman, E. J. (2004) · American Registry of PathologyWashington, DC eBooks · doi:10.55418/1881041883 · Cited by 433
Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene.
Yeung, R. S. W., Xiao, G. H., Jin, F., Lee, W. C., Testa, J. R., & Knudson, A. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11413 · Cited by 307

Show all 24 references

Research works printed but not linked: 7

O Iliopoulos, C Eng Semin Oncol 27, 138–149 (2000).
C D Malchoff, M Sarfarazi, B Tendler, F Forouhar, G Whalen, V Joshi, A Arnold, D M Malchoff J Clin Endocrinol Metab 85, 1758–1764 (2000).
B Delahunt, J N Eble Mod Pathol 10, 537–544 (1997).
L Kruglyak, M J Daly, M P Reeve-Daly, E S Lander Am J Hum Genet 58, 1347–1363 (1996).
R W Cottingham, R M Idury, A A Schaffer Am J Hum Genet 53, 252–263 (1993).
J I Everitt, D C Wolf, S R Howe, T L Goldsworthy, C Walker Am J Pathol 146, 1556–1567 (1995).
V E Reuter, J C Presti Semin Oncol 27, 124–137 (2000).

Sorted by citations

Items 201–300 of 675

Inherited kidney cancer syndromes
Ball, M. W., & Shuch, B. M. (2019) · Current Opinion in Urology · doi:10.1097/mou.0000000000000646 · Cited by 38
Disruption of tubular Flcn expression as a mouse model for renal tumor induction
Chen, J., Huang, D., Rubera, I., Futami, K., Wang, P., Zlckert, P., Khoo, S. K., Dykema, K. J., Zhao, P., Petillo, D., et al. (2015) · Kidney International · doi:10.1038/ki.2015.177 · Cited by 37
Metabolic Drivers in Hereditary Cancer Syndromes
Sciacovelli, M., Schmidt, C., Maher, E. R., & Frezza, C. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033612 · Cited by 39
Birt‐Hogg‐Dubé syndrome‐associated renal cell carcinoma: Histopathological features and diagnostic conundrum
Furuya, M., Hasumi, H., Yao, M., & Nagashima, Y. (2019) · Cancer Science · doi:10.1111/cas.14255 · Cited by 37
Fumarate hydratase inactivation in renal tumors: HIF1 alpha, NRF2, and "cryptic targets" of transcription factors
Ooi, A., & Furge, K. A. (2012) · 癌症：英文版 · doi:10.5732/cjc.012.10102 · Cited by 38
Understanding the natural biology of kidney cancer: implications for targeted cancer therapy.
Klatte, T., Pantuck, A. J., Kleid, M. D., & Belldegrun, A. S. (2007) · Europe PMC (PubMed Central) · Cited by 37
Imaging of hereditary renal cancer
Choyke, P. L. (2003) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(03)00068-x · Cited by 37
Renal cell carcinoma: Evolving and emerging subtypes
Crumley, S. M., Divatia, M. K., Truong, L. D., Shen, S. S., Ayala, A. G., & Ro, J. Y. (2013) · World Journal of Clinical Cases · doi:10.12998/wjcc.v1.i9.262 · Cited by 36
Familial and Hereditary Renal Cancer Syndromes
Coleman, J. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2008.07.014 · Cited by 36
The significance of gene mutations across eight major cancer types
Paul, P., Malakar, A. K., & Chakraborty, S. (2019) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2019.04.004 · Cited by 36
Prevalence of somatic and germline mutations of Fumarate hydratase in uterine leiomyomas from young patients
Liu, C., Dillon, J. L., Beavis, A., Liu, Y., Lombardo, K. A., Fader, A. N., Hung, C., Wu, T.-C., VANG, R. S., García, J. E., et al. (2019) · Histopathology · doi:10.1111/his.14007 · Cited by 36
Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study
Nikolovski, I., Carlo, M. I., Chen, Y., & Vargas, H. A. (2021) · Cancer Imaging · doi:10.1186/s40644-021-00392-9 · Cited by 36
Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma
Ylisaukko‐oja, S. K., Cybulski, C., Lehtonen, R., Kiuru, M. H., Trubicka, J., Szymañska, A., Szymańska-Pasternak, J., Dyrskjøt, L., Bützow, R. C., Orntoft, T. F., et al. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201630 · Cited by 35
Self-citation
Targeted therapies for non-clear renal cell carcinoma
Singer, E. A., Bratslavsky, G., Linehan, W. M., & Srinivasan, R. (2010) · Targeted Oncology · doi:10.1007/s11523-010-0148-3 · Cited by 35
Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell Carcinoma
Lang, M., Vocke, C. D., Ricketts, C. J., Metwalli, A. R., Ball, M. W., Schmidt, L. S., & Linehan, W. M. (2020) · Urology · doi:10.1016/j.urology.2020.11.025 · Cited by 35
Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas
Ahvenainen, T., Tolvanen, J., Kämpjärvi, K., Uimari, O., Ahtikoski, A., Mäkinen, N., Heikinheimo, O., Aaltonen, L. A., Karhu, A., Bützow, R., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001826 · Cited by 35
Self-citation
The evolving classification of renal cell neoplasia
Delahunt, B., & Srigley, J. R. (2015) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2015.02.002 · Cited by 35
Choice of Operation for Clinically Localized Renal Tumor
Nguyen, C. T., Campbell, S. C., & Novick, A. C. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2008.07.002 · Cited by 35
Role of Hormones in Common Benign Uterine Lesions: Endometrial Polyps, Leiomyomas, and Adenomyosis
Kossaï, M., & Penault-Llorca, F. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38474-6_3 · Cited by 41
Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report
Iribe, Y., Furuya, M., Shibata, Y., Yasui, M., Funahashi, M., Ota, J., Iwashita, H., Nagashima, Y., Hasumi, H., Hayashi, N., et al. (2020) · Familial Cancer · doi:10.1007/s10689-020-00195-0 · Cited by 35
Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors
Hamza, A., Sirohi, D., Smith, S. C., & Amin, M. B. (2021) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000321 · Cited by 35
Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma
Alaghehbandan, R., Stehlík, J., Trpkov, K., Magi‐Galluzzi, C., Condom, E., Pané, M., Berney, D. M., Sibony, M., Suster, S. M., Agaimy, A., et al. (2017) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2017.04.007 · Cited by 33
Recent advances in the biology of tumour hypoxia with relevance to diagnostic practice and tissue‐based research
Macklin, P. S., Yamamoto, A., Browning, L., Hofer, M., Adam, J., & Pugh, C. W. (2020) · The Journal of Pathology · doi:10.1002/path.5402 · Cited by 33
Strong family history of uterine leiomyomatosis warrants fumarate hydratase mutation screening
Tolvanen, J., Uimari, O., Ryynänen, M., Aaltonen, L. A., & Vahteristo, P. (2012) · Human Reproduction · doi:10.1093/humrep/des105 · Cited by 33
Self-citation
Comparative bioenergetic assessment of transformed cells using a cell energy budget platform
Zhdanov, A. V., Favre, C., O′Flaherty, L., Adam, J., O’Connor, R., Pollard, P. J., & Papkovsky, D. B. (2011) · Integrative Biology · doi:10.1039/c1ib00050k · Cited by 34
Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer
Ahvenainen, T., Lehtonen, H. J., Lehtonen, R., Vahteristo, P., Aittomäki, K., Baynam, G. S., Dommering, C. J., Eng, C., Gruber, S. B., Grönberg, H., et al. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.01.010 · Cited by 33
Self-citation
Fumarase is involved in DNA double-strand break resection through a functional interaction with Sae2
Leshets, M., Ramamurthy, D., Lisby, M., Lehming, N., & Pines, O. (2017) · Current Genetics · doi:10.1007/s00294-017-0786-4 · Cited by 33
Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer
Koski, T. A., Lehtonen, H. J., Jee, K. J., Ninomiya, S., Joosse, S. A., Vahteristo, P., Kiuru, M. H., Karhu, A., Sammalkorpi, H., Vanharanta, S., et al. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20663 · Cited by 32
Self-citation
Multiple cutaneous and uterine leiomyomata resulting from missense mutations in the fumarate hydratase gene.
Chuang, G. S., Martı́nez-Mir, A., Engler, D. E., Gmyrek, R., Zlotogorski, A., & Christiano, A. M. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01977.x · Cited by 32
Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma
Vocke, C. D., Ricketts, C. J., Merino, M. J., Srinivasan, R., Metwalli, A. R., Middelton, L. A., Peterson, J. C., Yang, Y., & Linehan, W. M. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22452 · Cited by 31
Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing
Lu, E., Hatchell, K. E., Nielsen, S. M., Esplin, E. D., Ouyang, K., Nykamp, K., Zavoshi, S., Li, S., Zhang, L., Wilde, B. R., et al. (2021) · Cancer · doi:10.1002/cncr.33997 · Cited by 31
10 rare tumors that warrant a genetics referral
Banks, K. C., Moline, J., Marvin, M. L., Newlin, A. C., & Vogel, K. J. (2012) · Familial Cancer · doi:10.1007/s10689-012-9584-9 · Cited by 30
The impact of RNA binding proteins and the associated long non-coding RNAs in the TCA cycle on cancer pathogenesis
Shen, T., Wang, H., Tang, B., Zhu, G., & Wang, X. (2023) · RNA Biology · doi:10.1080/15476286.2023.2216562 · Cited by 29
Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases
Pan, X., Zhang, M., Yao, J., Zeng, H., Nie, L., Gong, J., Chen, X., Xu, M., Zhou, Q., & Chen, N. (2019) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2019-205924 · Cited by 29
Precision Surgery and Kidney Cancer: Knowledge of Genetic Alterations Influences Surgical Management
Gomella, P. T., Linehan, W. M., & Ball, M. W. (2021) · Genes · doi:10.3390/genes12020261 · Cited by 29
Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma
Sager, R., Backe, S. J., Ahanin, E. F., Smith, G., Nsouli, I. S., Woodford, M. R., Bratslavsky, G., Bourboulia, D., & Mollapour, M. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00571-8 · Cited by 29
No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome
Vahteristo, P., Koski, T. A., Näätsaari, L., Kiuru, M. H., Karhu, A., Herva, R., Sallinen, S., Kuismin, O., Björck, E., Richard, S., et al. (2009) · Familial Cancer · doi:10.1007/s10689-009-9312-2 · Cited by 29
Self-citation
A View on Uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity
Koltsova, A. S., Efimova, O. A., & Pendina, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065752 · Cited by 31
No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas
Barker, K. T., Spendlove, H. E., Banu, N. S., Bridge, J. A., Fisher, C., SHIPLEY, J. M., Garrett, M. D., Manyonda, I., & Houlston, R. S. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.04.017 · Cited by 28
Tumorigenesis Mechanisms Found in Hereditary Renal Cell Carcinoma: A Review
Webster, B. R., Gopal, N., & Ball, M. W. (2022) · Genes · doi:10.3390/genes13112122 · Cited by 28
Tumour and patient factors in renal cell carcinoma—towards personalized therapy
Haddad, A., & Margulis, V. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.71 · Cited by 27
SWI/SNF protein expression status in fumarate hydratase–deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients
Agaimy, A., Amin, M. B., Gill, A. J., Popp, B., Reis, A., Berney, D. M., Magi‐Galluzzi, C., Sibony, M., Smith, S. C., Suster, S. M., et al. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.04.004 · Cited by 26
Cancer and the Kidney: The Growth of Onco-nephrology
Perazella, M. A., Berns, J. S., & Rosner, M. H. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.09.002 · Cited by 26
Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a tailored therapeutic approach
Wyvekens, N., Valtcheva, N., Mischo, A., Helmchen, B., Hermanns, T., Choschzick, M., Hötker, A. M., Rauch, A. M., Mühleisen, B., Akhoundova, D., et al. (2020) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22878 · Cited by 25
Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization
Sánchez‐Heras, A. B., Castillejo, A., García-Díaz, J. D. D., Robledo, M., Teulé, À., Sánchez‐Martínez, R., Zúñiga, Á., Lastra, E., Durán, M., Llort, G., et al. (2020) · Cancers · doi:10.3390/cancers12113277 · Cited by 25
Risk of Renal Cell Carcinoma After Hysterectomy
Altman, D. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.425 · Cited by 25
Increased HIF1α in SDH and FH deficient tumors does not cause microsatellite instability
Lehtonen, H. J., Mäkinen, M. J., Kiuru, M. H., Laiho, P., Herva, R., van Minderhout, I. J. H. M., Hogendoorn, P. C. W., Cornelisse, C. J., Devilee, P., Launonen, V., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22819 · Cited by 26
Self-citation
Multiple Cutaneous and Uterine Leiomyomas: Refinement of the Genetic Locus for Multiple Cutaneous and Uterine Leiomyomas on Chromosome 1q42.3–43
Martı́nez-Mir, A., Gordon, D., Horev, L., Klapholz, L., Ott, J., Christiano, A. M., & Zlotogorski, A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01741.x · Cited by 25
Familial Papillary Renal Cell Tumors and Subsequent Cancers: A Nationwide Epidemiological Study From Sweden
Czene, K., & Hemminki, K. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000052373.36963.12 · Cited by 25
Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma
Karivedu, V., Jain, A., Eluvathingal, T. J., & Sidana, A. (2019) · Current Urology Reports · doi:10.1007/s11934-019-0932-2 · Cited by 25
Constraint based modeling of metabolism allows finding metabolic cancer hallmarks and identifying personalized therapeutic windows
Bordel, S. (2018) · Oncotarget · doi:10.18632/oncotarget.24805 · Cited by 23
Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma
Xu, Y., Taylor, P. P., Andrade, J., Ueberheide, B. M., Shuch, B. M., Glazer, P. M., Bindra, R. S., Moran, M. F., Linehan, W. M., & Neel, B. G. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0901 · Cited by 24
Fumarate hydratase-deficient renal cell carcinoma: A clinicopathological study of seven cases including hereditary and sporadic forms
Kuroda, N., Tsutsui, M., Iguchi, M., Nobuoka, E., Uehara, T., Sonobe, Y., Morinaga, Y., Shibuya, S., Oda, W., Yanai, H., et al. (2020) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2020.151599 · Cited by 24
The role of mutation of metabolism-related genes in genomic hypermethylation
Waterfall, J. J., Killian, J. K., & Meltzer, P. S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.003 · Cited by 23
Impact of Genetics on the Diagnosis and Treatment of Renal Cancer
Singer, E. A., Bratslavsky, G., Middelton, L. A., Srinivasan, R., & Linehan, W. M. (2010) · Current Urology Reports · doi:10.1007/s11934-010-0156-y · Cited by 24
Role of DNA damage and repair mechanisms in uterine fibroid/leiomyomas: a review
Toprani, S. M., & Mane, V. K. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa157 · Cited by 23
Genodermatoses with Cutaneous Tumors and Internal Malignancies
Somoano, B., & Tsao, H. (2007) · Dermatologic Clinics · doi:10.1016/j.det.2007.08.011 · Cited by 23
Uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome can be identified through distinct clinical characteristics and typical morphology
Uimari, O., Ahtikoski, A. M., Kämpjärvi, K., Bützow, R. C., Järvelä, I. Y., Ryynänen, M., Aaltonen, L. A., Vahteristo, P., & Kuismin, O. (2021) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14248 · Cited by 24
Self-citation
Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas
Naik, H. B., Steinberg, S. M., Middelton, L. A., Hewitt, S. M., Zuo, R. C., Linehan, W. M., Kong, H. H., & Cowen, E. W. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.1793 · Cited by 22
Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development
Payson, M. D., Malik, M., Morris, S. S.-N., Segars, J. H., Chason, R. J., & Catherino, W. H. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.030 · Cited by 22
Leiomiomatosis cutánea y uterina múltiple o síndrome de Reed: estudio retrospectivo de 13 casos
Collgros, H., Iglesias‐Sancho, M., Tribó-Boixareu, M. J., Creus-Vila, L., Umbert-Millet, P., & Salleras‐Redonnet, M. (2014) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2014.08.005 · Cited by 22
Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC)
Wong, W., Tan, C. S., Lee, S. C., Yong, Y., Ooi, A. S., Ngeow, J. Y. Y., & Tan, M. H. (2014) · Familial Cancer · doi:10.1007/s10689-014-9703-x · Cited by 23
Mitochondrial dysfunction and risk of cancer
Lund, M., Melbye, M., Díaz, L. J., Dunø, M., Wohlfahrt, J., & Vissing, J. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.66 · Cited by 22
Genetics, Epigenetics and Cancer
Fymat, A. L. (2017) · Cancer therapy & Oncology International Journal · doi:10.19080/ctoij.2017.04.555634 · Cited by 23
Effects of metabolic cancer therapy on tumor microenvironment
Hyroššová, P., Milošević, M., Škoda, J., Vachtenheim, J., Jr., Rohlena, J., & Rohlenová, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1046630 · Cited by 23
Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas
Välimäki, N., Jokinen, V., Cajuso, T., Kuisma, H., Taira, A., Dagnaud, O., Ilves, S., Tolvanen, J., Pasanen, A. M., Palin, K., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.01.009 · Cited by 21
Self-citation
Hereditary Renal Cancer Syndromes
Yanus, G. A., Kuligina, E. S., & Имянитов, Е. Н. (2024) · Medical Sciences · doi:10.3390/medsci12010012 · Cited by 25
The Role of Inflammation in Sarcoma
Radons, J. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_11 · Cited by 22
Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome
Raymond, V. M., Herron, C. M., Giordano, T. J., & Gruber, S. B. (2011) · Familial Cancer · doi:10.1007/s10689-011-9485-3 · Cited by 21
Emerging Entities in Renal Neoplasia
Mehra, R., Smith, S. C., Divatia, M. K., & Amin, M. B. (2015) · Surgical pathology clinics · doi:10.1016/j.path.2015.08.004 · Cited by 21
Uterine Leiomyomata
Wise, L. A., & Laughlin-Tommaso, S. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00019-4 · Cited by 21
New potential regulators of uterine leiomyomata from DNA arrays: the ionotropic glutamate receptor GluR2
Tsibris, J. C. M., Maas, S., Segars, J. H., Nicosia, S. V., Enkemann, S. A., O’Brien, W. F., & Spellacy, W. N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.189 · Cited by 21
Update on the Epidemiology and Biology of Renal Cortical Neoplasms
Collins, S., McKiernan, J., & Landman, J. (2006) · Journal of Endourology · doi:10.1089/end.2006.20.975 · Cited by 21
Fumarate hydratase as a therapeutic target in renal cancer
Kancherla, P., Daneshvar, M., Sager, R., Mollapour, M., & Bratslavsky, G. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1804862 · Cited by 20
Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series
Kennedy, J. M., Wang, X., Plouffe, K. R., Dhanasekaran, S. M., Hafez, K., Palapattu, G. S., Else, T., Weizer, A. Z., Morgan, T. M., Spratt, D. E., et al. (2019) · Medical Oncology · doi:10.1007/s12032-019-1297-6 · Cited by 20
Five decades of urologic pathology: the accelerating expansion of knowledge in renal cell neoplasia
MacLennan, G. T., & Liang Cheng, C. (2019) · Human Pathology · doi:10.1016/j.humpath.2019.09.009 · Cited by 21
Genetic basis of kidney cancer: a model for developing molecular‐targeted therapies
Vira, M. A., Novakovic, K. R., Pinto, P. A., & Linehan, W. M. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.06814.x · Cited by 20
Genetic Basis of Bilateral Renal Cancer: Implications for Evaluation and Management
Linehan, W. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0045 · Cited by 20
Systematic molecular and clinical analysis of uterine leiomyomas from fertile-aged women undergoing myomectomy
Äyräväinen, A., Pasanen, A. M., Ahvenainen, T., Heikkinen, T., Pakarinen, P. I., Härkki, P., & Vahteristo, P. (2020) · Human Reproduction · doi:10.1093/humrep/deaa187 · Cited by 19
Cyst(e)inase–Rapamycin Combination Induces Ferroptosis in Both In Vitro and In Vivo Models of Hereditary Leiomyomatosis and Renal Cell Cancer
Kerimoglu, B., Lamb, C., McPherson, R. D., Ergen, E., Stone, E. M., & Ooi, A. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0661 · Cited by 19
Molecular pathways involved in hair follicle tumor formation: all about mammalian target of rapamycin?
Steensel, M. A. M. V., van Geel, M., Badeloe, S., Poblete‐Gutiérrez, P., & Frank, J. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00808.x · Cited by 19
Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression
Wu, M., Si, S., Li, Y., Schoen, S. R., Xiao, G., Li, X., Teh, B. T., Wu, G., & Chen, J. (2015) · Oncotarget · doi:10.18632/oncotarget.5018 · Cited by 19
Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines
Yang, Y., Ricketts, C. J., Vocke, C. D., Killian, J. K., Padilla‐Nash, H. M., Lang, M., Wei, D., Lee, Y. H., Wangsa, D., Sourbier, C., et al. (2021) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22940 · Cited by 18
Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP)
Ricketts, C. J., Killian, J. K., Vocke, C. D., Wang, Y., Merino, M. J., Meltzer, P. S., & Linehan, W. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278108 · Cited by 18
Multiple cutaneous and uterine leiomyomatosis syndrome: a review.
Choudhary, S., McLeod, M. P., Torchia, D., & Romanelli, P. (2013) · Europe PMC (PubMed Central) · Cited by 18
Multiple painful cutaneous nodules and renal mass
Rothman, A., Glenn, G. M., Choyke, L. T., Srinivasan, R., Linehan, W. M., & Cowen, E. W. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.06.026 · Cited by 18
Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 cases
Pivovarčíková, K., Martínek, P., Grossmann, P., Trpkov, K., Alaghehbandan, R., Magi‐Galluzzi, C., Pané, M., Condom, E., Berney, D. M., Gill, A. J., et al. (2019) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2019.02.008 · Cited by 18
Epidemiology of Renal Cell Carcinoma
Narayanan, S., Patel, P. H., Fan, A. C., & Srinivas, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_1 · Cited by 18
Type 2 Segmental Manifestation of Cutaneous Leiomyomatosis in Four Unrelated Women with Additional Uterine Leiomyomas (Reed’s Syndrome)
Ritzmann, S., Hanneken, S., Neumann, N. J., Ruzicka, T., & Kruse, R. (2005) · Dermatology · doi:10.1159/000089031 · Cited by 18
Evidence for a Founder Effect of the Germline Fumarate Hydratase Gene Mutation R58P causing Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)
Heinritz, W., Paasch, U., Sticherling, M., Wittekind, C., Simon, J. C., Froster, U., & Renner, R. (2007) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2007.00396.x · Cited by 17
Cascade Fumarate Hydratase mutation screening allows early detection of kidney tumour: a case report
Chan, M., Barnicoat, A. J., Mumtaz, F., Aitchison, M., Side, L. E., Brittain, H. K., Bates, A. W., & Gale, D. P. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0436-1 · Cited by 17
The molecular characterization and therapeutic strategies of papillary renal cell carcinoma
Chen, Q., Liang Cheng, C., & Li, Q. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1548939 · Cited by 17
Hereditary Leiomyomatosis and Renal Cell Cancer
Hansen, A., Chayed, Z., Pallesen, K. A. U., Vasilescu, I., & Bygum, A. (2019) · Acta Dermato Venereologica · doi:10.2340/00015555-3366 · Cited by 16
Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomas
Furuya, M., Iribe, Y., Nagashima, Y., Kambe, N., Ohe, C., Kinoshita, H., Sato, C., Kishida, T., Okubo, Y., Numakura, K., et al. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206548 · Cited by 17
Mesenchymal Tumors of the Uterus
Oliva, E., Zaloudek, C. J., & Soslow, R. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-46334-6_10 · Cited by 18
Update on Selected High-grade Renal Cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas
Chen, Y. (2023) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000426 · Cited by 16
Isolated cutaneous leiomyosarcoma revealing a novel germline mutation of the fumarate hydratase gene
Weiler, L., Poulalhon, N., Slama, A., Guillaud-Bataille, M., & Thomas, L. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13867 · Cited by 16
Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report
Kamai, T., Abe, H., Arai, K., Murakami, S., Sakamoto, S., Kaji, Y., & Yoshida, K. (2016) · BMC Cancer · doi:10.1186/s12885-016-2272-7 · Cited by 16
Biochemical Characterization of Two Clinically-Relevant Human Fumarase Variants Defective for Oligomerization
Bulku, A., Weaver, T. M., & Berkmen, M. B. (2018) · The Open Biochemistry Journal · doi:10.2174/1874091x01812010001 · Cited by 16
Fumarate Metabolic Signature for the Detection of Reed Syndrome in Humans
Casey, R. T., McLean, M. A., Challis, B., McVeigh, T. P., Warren, A. Y., Mendil, L., Houghton, R., de Sanctis, S., Kosmoliaptsis, V., Sandford, R. N., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1729 · Cited by 16

Authors: Launonen, V., Vierimaa, O., Kiuru, M., Isola, J., Roth, S., Pukkala, E., Sistonen, P., Herva, R., & Aaltonen, L. A.
Affiliations: University of Helsinki (FI)
Department of Medical Genetics, Haartman Institute, University of Helsinki, P. O. Box 21, FIN-00014, Helsinki, Finland; Department of Clinical Genetics, Oulu University Hospital, Kajaanintie 50, FIN-90220, Oulu, Finland; Institute of Medical Technology, University of Tampere, FIN-33014, Tampere, Finland; Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Finnish Cancer Registry, FIN-00170, Helsinki, Finland; Finnish Red Cross Blood Transfusion Service,...
ORCID: Kiuru, Maija
Isola, Jorma
Pukkala, Eero
Aaltonen, Lauri A.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2001-02-27
Volume: 98
Issue: 6
Pages: 3387-3392
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.051633798
PMC: PMC30663
OpenAlex: W2110394707
Cited by: 669
References: 24
Citations by year: 2026: 9 · 2025: 21 · 2024: 21 · 2023: 27 · 2022: 23 · 2021: 35 · 2020: 30 · 2019: 38 · 2018: 33 · 2017: 40 · 2016: 30 · 2015: 47 · 2014: 27 · 2013: 35 · 2012: 30
FWCI: 18.01
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Keywords: hereditary leiomyomatosis and renal cell carcinoma, uterine fibroids, papillary renal cell carcinoma, uterine leiomyosarcoma, tumor suppressor, hereditary cancer predisposition, dominant inheritance, metastatic renal cell carcinoma, histopathological diagnosis
MeSH terms: Adult, Carcinoma, Renal Cell, Chromosomes, Human, Female, Genetic Markers, Humans, Kidney Neoplasms, Leiomyoma, Leiomyosarcoma, Male, Middle Aged, Pedigree, Phenotype, Uterine Neoplasms, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inherited susceptibility to uterine leiomyomas and renal cell cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks